Dr. Borriello was a featured speaker at a live webinar entitled “Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as the ‘Next Big Thing’ in Cancer Immunotherapy”. The live webinar, moderated by Lumanity, brought together a diver...
Category: Audio Video
-
October 24, 2024
Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as a “Next Big Thing” in Cancer Immunotherapy
-
June 12, 2024
SITC23 Posters with Oral Presentation recording by Alloplex Biotherapeutics Inc’s Founder and Chief Executive Officer, Dr. Frank Borriello.
SITC 2023 Poster 381 and 727 with Audio Commentary by Dr. Borriello